Aurora Spine Corporation Announces Third Quarter 2024 Financial Results

1 year ago

- Company reports record revenue and net income - - Company to host conference call on Monday, October 28th at…

Synergy CHC Corp. Announces Closing of Initial Public Offering

1 year ago

WESTBROOK, Maine, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a provider of consumer health care,…

Vision Sensing Acquisition Corp. Announces Securities Suspension Date and Redemption Amount

1 year ago

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company” or “VSAC”),…

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

1 year ago

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global…

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement

1 year ago

CARSON CITY, Nev., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company…

The Ensign Group Reports Third Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance

1 year ago

Conference Call and Webcast scheduled for tomorrow, October 25, 2024 at 10:00 am PTSAN JUAN CAPISTRANO, Calif., Oct. 24, 2024…

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

1 year ago

Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ PlatformREDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE)…

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

1 year ago

ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality…

IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st

1 year ago

WINTER SPRINGS, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release…

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

1 year ago

MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing…